Drug potency of some medications may be reduced as a result of storage in BD disposable syringes. BD has determined that the decreased potency is due to an interaction of some drugs with one of the two types of rubber stoppers in these syringes. This reduction in drug potency can result in a decrease in drug effectiveness.
To date, decreased potency has been reported to BD for the following drugs: fentanyl, rocuronium, neostigmine, morphine, midazolam, methadone, atropine, HYDROmorphone, cisatracurium, and remifentanyl. Since these drugs are used in pain management and as a component of an anesthetic regimen, a decrease in drug potency can potentially result in loss of pain control.
At this time, Health Canada does not know whether other drugs stored in syringes made by other manufacturers with similar rubber stoppers may be affected. There have been no reports of serious injury. To date, no Canadian cases related to drug potency issues have been confirmed.
Products affected
BD sterile plastic disposable syringes: BD utilizes a primary and an alternate rubber stopper supplier for these syringes. Reported complaints of drug potency loss were confirmed by BD to be with syringes using the alternate stopper.
Affected lots include: 3 mL, 5 mL, 10 mL and 30 mL BD syringes, and BD oral/enteral syringes. Consult the
BD Web site to determine if syringes in your use are affected.
Please note that BD Insulin Syringes, BD PosiFlush™ Pre-filled Saline and Heparin Syringes, and BD Pharmaceutical Systems’ prefillable syringes do not use the rubber stopper associated with this issue.
Background information
BD general purpose disposable syringes are intended for fluid aspiration and prompt administration of fluids only. BD disposable syringes are NOT intended for drug storage.
To date, BD received several reports from customers in the US (all of whom prefill syringes with drugs) related to loss of drug potency when some drug products were stored for periods of time (exact timeframes unknown) in BD 3 mL and 5 mL syringes that had the alternate stopper.
BD has conducted initial testing for drug potency with fentanyl. A 10 % reduction in potency was noted within 12 hrs of filling a 5 mL syringe with 2 mL of fentanyl at a concentration of 5 µg/mL when stored in a syringe with the alternate stopper. When syringes are filled and used promptly, there is no evidence of decreased drug potency with the primary and alternate stoppers. BD is conducting additional testing with other drugs to further characterize the issue.